1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Aeterna Zentaris Inc.

Aeterna Zentaris Inc.

AEZS.TO
Aeterna Zentaris Inc.CA flagToronto Stock Exchange
8.29
CAD
+0.62
- -
25.38MMarket Cap

Total Valuation

Aeterna Zentaris Inc. carries a market capitalization of 25.38M, placing it among publicly traded companies globally. Its enterprise value stands at -14.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap25.38M
Enterprise Value-14.15M

Share Statistics

Aeterna Zentaris Inc. currently has 3.06M shares outstanding.

Shares Outstanding3.06M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.55, and the price-to-book ratio stands at 0.51.

PE RatioN/A
PS Ratio1.55
PB Ratio0.51
P/TBV Ratio0.52
P/FCF Ratio-3.42
P/OCF Ratio-2.46

Enterprise Valuation

EV / Sales5.05
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Aeterna Zentaris Inc. maintains a current ratio of 3.36, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.43, indicating elevated leverage, while an interest coverage ratio of -80.18 demonstrates limited ability to service its debt obligations.

Current Ratio3.36
Quick Ratio2.95
Debt / Equity6.43
Debt / EBITDA-0.23
Interest Coverage-80.18

Financial Efficiency

Return on Equity (ROE)-24.26
Return on Assets (ROA)-13.77
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.43

Taxes

Income Tax-1.48M
Effective Tax RateN/A

Stock Price Statistics

Aeterna Zentaris Inc.'s stock has declined approximately -39.22287% over the past 52 weeks. The 50-day moving average sits at 7.81, while the 200-day moving average is 7.33.

Beta (5Y)N/A
52-Week Price Change-39.22287%
50-Day Moving Average7.81
200-Day Moving Average7.33
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Aeterna Zentaris Inc. generated 7.71M in revenue and converted that into -5.24M in net income, yielding earnings per share of -2.66. EBITDA reached -7.33M, while operating income came in at -8.82M.

Revenue7.71M
Gross Profit2.73M
Operating Income-8.82M
Pretax Income-6.71M
Net Income-5.24M
EBITDA-7.33M
EBIT-8.82M
Earnings Per Share (EPS)-2.66

Balance Sheet

Aeterna Zentaris Inc. holds 27.80M in cash and equivalents against 1.69M in total debt, resulting in a net debt position of -27.80M. Total book value stands at 23.54M, with working capital of 23.31M providing operational flexibility.

Cash & Cash Equivalents27.80M
Total Debt1.69M
Net Debt-27.80M
Equity (Book Value)23.54M
Book Value Per Share11.94
Working Capital23.31M

Cash Flow

Aeterna Zentaris Inc. produced -4.87M in operating cash flow over the past twelve months. After subtracting -1.37M in capital expenditures, free cash flow totaled -6.25M - equivalent to -3.17 per share.

Operating Cash Flow-4.87M
Capital Expenditures-1.37M
Free Cash Flow-6.25M
FCF Per Share-3.17

Margins

Aeterna Zentaris Inc. operates with a gross margin of 35.48, reflecting its pricing power and cost economics. The operating margin of -114.42 and net profit margin of -67.98 provide insight into operational efficiency.

Gross Margin35.48
Operating Margin-114.42
Pretax Margin-87.14
Profit Margin-67.98
EBITDA Margin-95.18

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield2.83
FCF Yield-29.24

Stock Splits

Aeterna Zentaris Inc.'s most recent stock split took place on June 7, 2024 with a 2500:59 split ratio.

Last Split Date6/7/2024
Split Ratio2500:59

Scores

Aeterna Zentaris Inc. posts an Altman Z-Score of 0.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.49